Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis
Phase 4
Completed
- Conditions
- BlepharitisSigns and Symptoms
- Interventions
- Drug: Placebo Comparator
- First Posted Date
- 2011-05-20
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Ursapharm Arzneimittel GmbH
- Target Recruit Count
- 197
- Registration Number
- NCT01357538
- Locations
- 🇺🇦
Kharkov District Clinical Hospital, Kharkov, Ukraine
© Copyright 2025. All Rights Reserved by MedPath